CA Stock MarketDetailed Quotes

NGEN NervGen Pharma Corp

Watchlist
  • 2.520
  • 0.0000.00%
15min DelayMarket Closed Sep 13 16:00 ET
176.85MMarket Cap-6631P/E (TTM)

NervGen Pharma Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
65.15%26.56M
68.15%30.3M
-48.07%11.66M
-48.07%11.66M
-46.62%14.79M
38.06%16.08M
40.48%18.02M
32.62%22.45M
32.62%22.45M
235.78%27.7M
-Cash and cash equivalents
65.15%26.56M
68.15%30.3M
-48.07%11.66M
-48.07%11.66M
-46.62%14.79M
38.06%16.08M
40.48%18.02M
32.62%22.45M
32.62%22.45M
235.78%27.7M
-Accounts receivable
-71.21%11.55K
-84.95%13.58K
825.77%250.21K
825.77%250.21K
-12.00%23.33K
-58.57%40.11K
29.08%90.19K
-57.77%27.03K
-57.77%27.03K
-36.85%26.51K
Total current assets
63.12%27.34M
68.95%31.1M
-45.93%12.52M
-45.93%12.52M
-44.52%15.6M
37.44%16.76M
37.12%18.41M
32.88%23.15M
32.88%23.15M
216.28%28.12M
Non current assets
-Long term equity investment
-62.05%57.71K
-53.18%81.84K
-46.45%105.6K
-46.45%105.6K
-41.15%129.02K
-36.89%152.08K
--174.8K
--197.19K
--197.19K
--219.24K
-Goodwill
20.05%492.86K
20.39%506.8K
20.71%520.75K
20.71%520.75K
21.02%534.7K
-9.23%410.53K
-9.02%420.97K
-8.82%431.4K
-8.82%431.4K
-8.63%441.84K
Regulatory assets
164.08%105.92K
-84.95%13.58K
825.77%250.21K
825.77%250.21K
-12.00%23.33K
-58.57%40.11K
29.08%90.19K
-57.77%27.03K
-57.77%27.03K
-36.85%26.51K
Non current deferred assets
--57.71K
----
----
----
----
----
----
----
----
----
Liabilities
Current liabilities
Current debt and capital lease obligation
6.17%94.37K
6.17%92.97K
6.17%91.59K
6.17%91.59K
6.17%90.23K
6.17%88.89K
--87.57K
--86.27K
--86.27K
--84.99K
-Current capital lease obligation
6.17%94.37K
6.17%92.97K
6.17%91.59K
6.17%91.59K
6.17%90.23K
6.17%88.89K
--87.57K
--86.27K
--86.27K
--84.99K
-accounts payable
-36.91%559.45K
154.36%802.87K
-72.51%550.4K
-72.51%550.4K
-39.75%632.33K
-47.73%886.76K
-61.69%315.65K
467.85%2M
467.85%2M
70.12%1.05M
-Total tax payable
-62.05%57.71K
-53.18%81.84K
-46.45%105.6K
-46.45%105.6K
-41.15%129.02K
-36.89%152.08K
--174.8K
--197.19K
--197.19K
--219.24K
-Due to related parties current
947.58%2.77M
237.26%421.93K
-13.04%438.58K
-13.04%438.58K
102.56%456.16K
7.77%264.06K
-6.34%125.1K
84.03%504.35K
84.03%504.35K
-18.95%225.2K
-Other payable
----
----
----
----
----
----
----
----
----
---100
Current accrued expenses
-75.55%401.38K
35.53%2.22M
161.42%2.33M
161.42%2.33M
130.78%1.89M
95.19%1.64M
911.74%1.64M
97.61%892.14K
97.61%892.14K
331.25%820.15K
Current liabilities
58.10%15.34M
42.36%12.88M
48.18%15.14M
48.18%15.14M
8.52%11.12M
238.55%9.7M
708.02%9.04M
847.70%10.22M
847.70%10.22M
844.77%10.25M
Non current liabilities
-Long term debt
-62.05%57.71K
-53.18%81.84K
-46.45%105.6K
-46.45%105.6K
-41.15%129.02K
-36.89%152.08K
--174.8K
--197.19K
--197.19K
--219.24K
Non current accrued expenses
-98.96%2.57K
-34.64%175.43K
-32.34%199.78K
-32.34%199.78K
-29.79%224.46K
-27.02%246.8K
3,662.48%268.42K
10,872.87%295.28K
10,872.87%295.28K
9,134.43%319.7K
Total non current liabilities
56.24%15.4M
40.55%12.96M
46.39%15.25M
46.39%15.25M
7.48%11.25M
217.19%9.86M
723.64%9.22M
865.99%10.41M
865.99%10.41M
864.98%10.47M
Shareholders'equity
Share capital
36.61%80.04M
37.37%79.78M
2.65%58.93M
2.65%58.93M
3.48%58.76M
29.47%58.59M
36.49%58.08M
35.39%57.41M
35.39%57.41M
81.86%56.78M
-common stock
36.61%80.04M
37.37%79.78M
2.65%58.93M
2.65%58.93M
3.48%58.76M
29.47%58.59M
36.49%58.08M
35.39%57.41M
35.39%57.41M
81.86%56.78M
Gains losses not affecting retained earnings
46.19%20.77M
59.15%19.54M
45.62%17.21M
45.62%17.21M
38.68%15.89M
29.69%14.21M
19.93%12.28M
24.90%11.82M
24.90%11.82M
43.76%11.46M
Total equity
60.14%27.89M
66.42%31.78M
-44.56%13.24M
-44.56%13.24M
-43.36%16.36M
34.13%17.42M
37.45%19.1M
33.41%23.88M
33.41%23.88M
207.97%28.88M
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 65.15%26.56M68.15%30.3M-48.07%11.66M-48.07%11.66M-46.62%14.79M38.06%16.08M40.48%18.02M32.62%22.45M32.62%22.45M235.78%27.7M
-Cash and cash equivalents 65.15%26.56M68.15%30.3M-48.07%11.66M-48.07%11.66M-46.62%14.79M38.06%16.08M40.48%18.02M32.62%22.45M32.62%22.45M235.78%27.7M
-Accounts receivable -71.21%11.55K-84.95%13.58K825.77%250.21K825.77%250.21K-12.00%23.33K-58.57%40.11K29.08%90.19K-57.77%27.03K-57.77%27.03K-36.85%26.51K
Total current assets 63.12%27.34M68.95%31.1M-45.93%12.52M-45.93%12.52M-44.52%15.6M37.44%16.76M37.12%18.41M32.88%23.15M32.88%23.15M216.28%28.12M
Non current assets
-Long term equity investment -62.05%57.71K-53.18%81.84K-46.45%105.6K-46.45%105.6K-41.15%129.02K-36.89%152.08K--174.8K--197.19K--197.19K--219.24K
-Goodwill 20.05%492.86K20.39%506.8K20.71%520.75K20.71%520.75K21.02%534.7K-9.23%410.53K-9.02%420.97K-8.82%431.4K-8.82%431.4K-8.63%441.84K
Regulatory assets 164.08%105.92K-84.95%13.58K825.77%250.21K825.77%250.21K-12.00%23.33K-58.57%40.11K29.08%90.19K-57.77%27.03K-57.77%27.03K-36.85%26.51K
Non current deferred assets --57.71K------------------------------------
Liabilities
Current liabilities
Current debt and capital lease obligation 6.17%94.37K6.17%92.97K6.17%91.59K6.17%91.59K6.17%90.23K6.17%88.89K--87.57K--86.27K--86.27K--84.99K
-Current capital lease obligation 6.17%94.37K6.17%92.97K6.17%91.59K6.17%91.59K6.17%90.23K6.17%88.89K--87.57K--86.27K--86.27K--84.99K
-accounts payable -36.91%559.45K154.36%802.87K-72.51%550.4K-72.51%550.4K-39.75%632.33K-47.73%886.76K-61.69%315.65K467.85%2M467.85%2M70.12%1.05M
-Total tax payable -62.05%57.71K-53.18%81.84K-46.45%105.6K-46.45%105.6K-41.15%129.02K-36.89%152.08K--174.8K--197.19K--197.19K--219.24K
-Due to related parties current 947.58%2.77M237.26%421.93K-13.04%438.58K-13.04%438.58K102.56%456.16K7.77%264.06K-6.34%125.1K84.03%504.35K84.03%504.35K-18.95%225.2K
-Other payable ---------------------------------------100
Current accrued expenses -75.55%401.38K35.53%2.22M161.42%2.33M161.42%2.33M130.78%1.89M95.19%1.64M911.74%1.64M97.61%892.14K97.61%892.14K331.25%820.15K
Current liabilities 58.10%15.34M42.36%12.88M48.18%15.14M48.18%15.14M8.52%11.12M238.55%9.7M708.02%9.04M847.70%10.22M847.70%10.22M844.77%10.25M
Non current liabilities
-Long term debt -62.05%57.71K-53.18%81.84K-46.45%105.6K-46.45%105.6K-41.15%129.02K-36.89%152.08K--174.8K--197.19K--197.19K--219.24K
Non current accrued expenses -98.96%2.57K-34.64%175.43K-32.34%199.78K-32.34%199.78K-29.79%224.46K-27.02%246.8K3,662.48%268.42K10,872.87%295.28K10,872.87%295.28K9,134.43%319.7K
Total non current liabilities 56.24%15.4M40.55%12.96M46.39%15.25M46.39%15.25M7.48%11.25M217.19%9.86M723.64%9.22M865.99%10.41M865.99%10.41M864.98%10.47M
Shareholders'equity
Share capital 36.61%80.04M37.37%79.78M2.65%58.93M2.65%58.93M3.48%58.76M29.47%58.59M36.49%58.08M35.39%57.41M35.39%57.41M81.86%56.78M
-common stock 36.61%80.04M37.37%79.78M2.65%58.93M2.65%58.93M3.48%58.76M29.47%58.59M36.49%58.08M35.39%57.41M35.39%57.41M81.86%56.78M
Gains losses not affecting retained earnings 46.19%20.77M59.15%19.54M45.62%17.21M45.62%17.21M38.68%15.89M29.69%14.21M19.93%12.28M24.90%11.82M24.90%11.82M43.76%11.46M
Total equity 60.14%27.89M66.42%31.78M-44.56%13.24M-44.56%13.24M-43.36%16.36M34.13%17.42M37.45%19.1M33.41%23.88M33.41%23.88M207.97%28.88M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data